CompletedPhase 1NCT00874562

Rapamycin in Relapsed Acute Lymphoblastic Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dana-Farber Cancer Institute
Principal Investigator
Lewis Silverman, MD
Dana-Farber Cancer Institute
Intervention
Corticosteroid(drug)
Enrollment
6 enrolled
Eligibility
All sexes
Timeline
20072016

Study locations (1)

Collaborators

Brigham and Women's Hospital · Boston Children's Hospital · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00874562 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials